Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Fischer

Showing results (241-250 of 323) with videos related to

Pageof 33
Sort By:
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Communications Biology|April 11, 2026
Accurate prediction of ecDNA in interphase cancer cells using deep neural networksGino Prasad, Utkrisht Rajkumar, Ellis J Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid TumorsBirgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Molecular Oncology|April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4SJean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signatureKatleen De Preter, Joëlle Vermeulen, Benedikt Brors, et al.
Oncotarget|March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human diseaseBram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Special Circumstances in ResuscitationCarsten Lott, Vlasios Karageorgos, Cristian Abelairas-Gomez, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastomaShahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
Scientific Reports|January 16, 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressivenessLiselot M Mus, Irina Lambertz, Shana Claeys, et al.
Pageof 33

Showing results (241-250 of 323) with videos related to

Sort By:
Pageof 33
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Communications Biology|April 11, 2026
Accurate prediction of ecDNA in interphase cancer cells using deep neural networksGino Prasad, Utkrisht Rajkumar, Ellis J Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid TumorsBirgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Molecular Oncology|April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4SJean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signatureKatleen De Preter, Joëlle Vermeulen, Benedikt Brors, et al.
Oncotarget|March 2, 2018
The mutational landscape of <i>MYCN</i>, <i>Lin28b</i> and <i>ALK</i><sup></sup> driven murine neuroblastoma mimics human diseaseBram De Wilde, Anneleen Beckers, Sven Lindner, et al.
Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Special Circumstances in ResuscitationCarsten Lott, Vlasios Karageorgos, Cristian Abelairas-Gomez, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastomaShahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
Scientific Reports|January 16, 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressivenessLiselot M Mus, Irina Lambertz, Shana Claeys, et al.
Pageof 33